The future is looking financially bright, Coca-Cola shares rise after Q1 beat, raised outlook Coca-Cola raised its full-year earnings forecast and reported first-quarter results that topped Wall Street estimates.Shares rose more than 2% in premarket trading...
Time to make an offer, Merck clears HSR waiting period for $53 per share acquisition Merck (NYSE: MRK) announced that the Hart-Scott-Rodino Act waiting period for its acquisition of Terns Pharmaceuticals (TERN) expired on April 23, 2026, at 11:59 p.m. Eastern Time.The...
Liquidating assets for cash, S&P Global sells energy software portfolio to SLB, launches AI platform S&P Global (NYSE: SPGI) announced it will sell its geoscience and petroleum engineering software portfolio to SLB, a global technology company, as part of a...
Chinese Market is booming, Tesla China sales rise 8.7% in March, extending five-month streak Tesla’s China-made electric vehicle sales increased 8.7% year-over-year to 85,670 units in March, marking the fifth consecutive month of growth for the U.S. automaker.Sales of...
Picking sides, Delta picks Amazon Leo for in-flight Wi-Fi in blow to Starlink Delta Air Lines Inc. signed an agreement with Amazon.com Inc. to use its Leo satellite service for in-flight Wi-Fi, marking a significant customer win for the e-commerce company’s space...
Putting your money where your mouth is, Royalty Pharma partners with J&J on $500M drug development deal Royalty Pharma plc (RPRX) announced a research and development co-funding agreement with Johnson & Johnson for $500 million over 2026 and 2027 to...
